02Nov 2024
Comparative Efficacy of AADI vs. BGI in Refractory Glaucoma

Comparative Efficacy of AADI vs. BGI in Refractory Glaucoma

This study compares the efficacy and safety of the Aurolab Aqueous Drainage Implant (AADI) and the Baerveldt Glaucoma Implant (BGI) in treating refractory glaucoma. An analysis of three studies involving 176 patients showed a borderline significant reduction in intraocular pressure (IOP) favoring AADI at three months. Both implants demonstrated similar surgical success rates and complication rates, highlighting AADI as a promising alternative. Further research is needed to confirm these results and explore cost-effectiveness, especially in resource-limited settings.

  • #ophthalmology

Like

Save

Share